Interpreting Rituximab Response in Seronegative Membranous Nephropathy [Letter]
Drug Design, Development and Therapy · 2026-05 · Volume 20 · 1-2
DOI: 10.2147/dddt.s626184 ↗Kurz gefasst
Leserbrief in der Zeitschrift Drug Design, Development and Therapy, 2026-05. Verfasst von Haixing Cao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning Province, People's Republic of China. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Haixing Cao,* Lidetian Hu,* Xiang Ma Department of Ophthalmology, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning Province, People’s Republic of China*These authors contributed equally to this workCorrespondence: Xiang Ma, Department of Ophthalmology, The First Affiliated Hospital of Dalian Medical University, 222 Zhongshan Road, Dalian City, Liaoning Province, People’s Republic of China, Tel +8618098876399, Email xma9467@vip.sina.com
Autor:innen und Institutionen
- Department of Ophthalmology, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning Province, People's Republic of China.
ORCID-Profile: Haixing Cao, Xiang Ma
Zitieren
APA
Cao, H., Hu, L., & Ma, X. (2026). Interpreting Rituximab Response in Seronegative Membranous Nephropathy [Letter]. Drug Design, Development and Therapy, Volume 20, 1-2. https://doi.org/10.2147/dddt.s626184
Vancouver
Cao H, Hu L, Ma X. Interpreting Rituximab Response in Seronegative Membranous Nephropathy [Letter]. Drug Design, Development and Therapy. 2026;Volume 20:1-2. doi:10.2147/dddt.s626184
BibTeX
@article{Cao2026,
author = {Cao, Haixing and Hu, Lidetian and Ma, Xiang},
title = {Interpreting Rituximab Response in Seronegative Membranous Nephropathy [Letter]},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--2},
doi = {10.2147/dddt.s626184}
}
EUVIMED